Evidence map›Paper›PMID 31189399›Full record

ReviewChannels (Austin, Tex.)2019

The potential role of TRPV1 in pulmonary hypertension: Angel or demon?

Xin Zhang, Lifang Ye, Yu Huang, Xueyan Ding, Lihong Wang

Open access · goldAbstract readReview
In one paragraph

Review in Channels (Austin, Tex.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Role of macrophage polarization in osteoarthritis (Review).Experimental and therapeutic medicine · 2022
    Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. TRPC and TRPV Channels' Role in Vascular Remodeling and Disease.International journal of molecular sciences · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Xin Zhanga The Second Clinical Medical College, Zhejiang Chinese Medical University , Hangzhou , China.
Lifang Yeb Department of Cardiovascular Medicine , Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College , Hangzhou , China.
Yu Huangb Department of Cardiovascular Medicine , Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College , Hangzhou , China.
Xueyan Dingb Department of Cardiovascular Medicine , Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College , Hangzhou , China.
Lihong Wanga The Second Clinical Medical College, Zhejiang Chinese Medical University , Hangzhou , China.
Hangzhou Medical College · CNZhejiang Provincial People's Hospital · CNZhejiang Chinese Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pulmonary hypertension (PH) is a pathological state defined by increased pulmonary artery pressure, the pathogenesis of which is related to genetic mutations, intracellular calcium ([Ca

Indexed as

AnimalsCalciumHumansHypertension, PulmonaryNeuropeptidesTRPV Cation ChannelsCalciumNeuropeptidesTRPV1 protein, humanTRPV1 receptorTRPV Cation ChannelsCainflammationneuropeptidesPulmonary hypertensiontransient receptor potential vanilloid subfamily member 1

Identifiers

PMID31189399
PMCPMC6602577
OpenAlexW2949854375

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.